Skeletal Muscle Loss Is an Independent Negative Prognostic Factor in Patients With Advanced Lower Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

PLoS ONE - United States
doi 10.1371/journal.pone.0195406
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Role of Autophagy-Related Protein Expression in Patients With Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Neoadjuvant Chemoradiotherapy in Combined Treatment of Patients With Rectal Cancer

Grekov's Bulletin of Surgery
2017English

Prognostic Significance of Lung Radiation Dose in Patients With Esophageal Cancer Treated With Neoadjuvant Chemoradiotherapy

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

MicroRNA Expression Profile Associated With Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

EMMPRIN Is an Independent Negative Prognostic Factor for Patients With Astrocytic Glioma

PLoS ONE
Multidisciplinary
2013English

Analysis of Early Postoperative Morbidity Among Patients With Rectal Cancer Treated With and Without Neoadjuvant Chemoradiotherapy

Annals of Surgical Oncology
OncologySurgery
2007English

Recent Advances in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Journal of the Anus, Rectum and Colon
2017English

Neoadjuvant Chemoradiotherapy in Rectal Cancer

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

A Novel LARCassigner3 Classification Predicts Outcomes in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Training and Validation Analysis

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy